Compound 401 is a cell-permeable pyrimido-isoquinolinone compound that acts as a potent, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 280 nM) with ~19-fold selectivity over mTOR (FRAP) (IC50 = 5.3 μM). Compound 401 exhibits much reduced or no activity against 43 other commonly studied kinases, including PI 3-K, ATM, and ATR. Compound 401 has been shown to induce apoptosis and inhibit FRAP-dependent growth in TSC1-/- murine embryo fibroblasts.
Ballou, L.M., et al. 2007. J. Biol. Chem. 282, 24463. Griffin, R.J., et al. 2005. J. Med. Chem. 48, 569
See how others have used Compound 401 (CAS 168425-64-7). Click on the entry to view the PubMed entry .
PMID: # 23373904 Shepelev, MV. et al. 2013. Mol. Pharm. 10: 931-9.
PMID: # 17562705 Ballou, LM. et al. 2007. J. Biol. Chem. 282: 24463-24470.
PMID: # 12941142 Tamai, R. et al. 2003. Immunology. 110: 66-72.
PMID: # 1937825 Wang, MH. et al. 1991. Infect. Immun. 59: 4655-4664.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.